|1.||Suzuki, Koji: 5 articles (06/2015 - 06/2003)|
|2.||Hayashi, Tatsuya: 5 articles (06/2015 - 06/2003)|
|3.||Lindblad, Bengt: 5 articles (11/2013 - 05/2006)|
|4.||Strandberg, Karin: 5 articles (01/2009 - 01/2006)|
|5.||Stenflo, Johan: 5 articles (01/2009 - 01/2006)|
|6.||Kölbel, Tilo: 4 articles (07/2010 - 05/2006)|
|7.||Nishioka, Junji: 3 articles (06/2015 - 02/2004)|
|8.||Asanuma, Kunihiro: 3 articles (06/2015 - 02/2004)|
|9.||Akita, Nobuyuki: 3 articles (06/2015 - 02/2004)|
|10.||Gottsäter, Anders: 3 articles (11/2013 - 05/2009)|
|1.||Disseminated Intravascular Coagulation
01/01/2004 - "Protein C inhibitor as an anti-disseminated intravascular coagulation agent--mechanism and modification."
07/01/2000 - "Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats."
07/01/2000 - "The effect of urinary protein C inhibitor (uPCI) on disseminated intravascular coagulation (DIC) was investigated using an experimental DIC in rats. "
08/31/1984 - "We measured levels of protein C inhibitor in patients with disseminated intravascular coagulation (DIC) and liver disease using a functional assay. "
09/01/2000 - "We compared urinary protein C inhibitor (uPCI) with low molecular weight heparin (LMWH) in terms of the effect on the pathophysiology of disseminated intravascular coagulation (DIC), such as hypercoagulation, induction of secondary fibrinolysis and organ failure, using lipopolysaccharide (LPS)-induced DIC in rats. "
09/01/2013 - "In this study we analyzed the protein C inhibitor gene mutations in Turkish pediatric stroke patients. "
09/01/2013 - "A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation."
01/01/2009 - "Ninety-seven stroke patients were prospectively investigated in a multicenter design with blood levels of brain biomarkers S100B, neuron specific enolase (NSE), glial fibrillary acidic protein (GFAP) as well as a coagulation biomarker, activated protein C-protein C inhibitor complex (APC-PCI), within 24 hours of symptom onset. "
|3.||Breast Neoplasms (Breast Cancer)
01/01/2007 - "To our knowledge this is the first study of the expression and role of PAI-3 in human breast cancer tissue. "
01/01/2007 - "Our results indicate that PAI-3 is expressed in human breast cancer tissues, and that elevated levels of PAI-3 could be a positive prognostic factor in this disease. "
09/01/2007 - "Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity."
01/01/2007 - "Protein and mRNA levels were evaluated for uPA, PAI-1 and PAI-3 in breast cancer tissues from 70 different patients. "
|4.||Interstitial Lung Diseases (Interstitial Lung Disease)
06/15/2003 - "This study evaluated the levels of thrombin-activatable fibrinolysis inhibitor and protein C inhibitor, another suppressor of fibrinolysis, in the bronchoalveolar lavage fluid from patients with interstitial lung disease. "
06/15/2003 - "Overall, these findings suggest that thrombin-activatable fibrinolysis inhibitor and protein C inhibitor may play important roles in the mechanism of intraalveolar hypofibrinolysis associated with interstitial lung diseases."
06/15/2003 - "The bronchoalveolar lavage fluid levels of thrombin-activatable fibrinolysis inhibitor and protein C inhibitor were significantly higher in all patients with interstitial lung disease than in normal subjects. "
06/15/2003 - "Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease."
|5.||Wegener Granulomatosis (Wegener's Granulomatosis)
02/01/2001 - "The polymorphic protease inhibitor (PI) gene is part of a cluster of serine protease inhibitor (serpin) genes (AACT; alpha1-antichymotrypsin, PCI; protein C inhibitor, CBG; corticosteroid binding globulin, PIL; PI-like pseudogene) at chromosome 14q32.1. In this study we investigated whether the serpin gene cluster contributes to the background of Wegener's granulomatosis. "
|2.||Plasminogen Activators (Plasminogen Activator)
|4.||Serine Proteases (Serine Protease)
|6.||Carboxypeptidase U (TAFI)
|8.||Protease Inhibitors (Protease Inhibitor)
|9.||Calcium Gluconate (CBG)
|10.||Protein C Inhibitor
|1.||Renal Dialysis (Hemodialysis)
|2.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|3.||Coronary Balloon Angioplasty (Percutaneous Transluminal Coronary Angioplasty)
|4.||Heterologous Transplantation (Xenotransplantation)